Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide

Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

(2013) Daniel T. Leung et al.   Clinical and Vaccine Immunology

Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates

(2013) Pumtiwitt C. McCarthy et al.   GLYCOCONJUGATE JOURNAL

Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 Serotype Ogawa with emphasis on antigenic density and chain length

(2013) Peter Ftacek et al.   GLYCOCONJUGATE JOURNAL

Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen ofVibrio cholerae, serotypeOgawaand the recombinant tetanus toxin C-fragment carrier

(2013) Farid Jahouh et al.   JOURNAL OF MASS SPECTROMETRY

Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies

(2013) Cyrille Grandjean et al.   Pathogens and Disease

The global burden of cholera

(2012) Mohammad Ali et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera

(2012) Mohammad Arifuzzaman et al.   Clinical and Vaccine Immunology

Comparison of Immune Responses to the O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi Adult Patients with Cholera

(2012) Russell A. Johnson et al.   Clinical and Vaccine Immunology

Transcutaneous Immunization with a Vibrio cholerae O1 Ogawa Synthetic Hexasaccharide Conjugate following Oral Whole-Cell Cholera Vaccination Boosts Vibriocidal Responses and Induces Protective Immunity in Mice

(2012) A. A. Tarique et al.   Clinical and Vaccine Immunology

Memory B Cell Responses to Vibrio cholerae O1 Lipopolysaccharide Are Associated with Protection against Infection from Household Contacts of Patients with Cholera in Bangladesh

(2012) Sweta M. Patel et al.   Clinical and Vaccine Immunology

Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

(2012) Daniel T. Leung et al.   Clinical and Vaccine Immunology

Immune responses to cholera in children

(2012) Daniel T Leung et al.   Expert Review of Anti-Infective Therapy

Cholera

(2012) Jason B Harris et al.   LANCET

The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens

(2012) Susannah Leach et al.   PLoS One

Simple, Direct Conjugation of Bacterial O-SP–Core Antigens to Proteins: Development of Cholera Conjugate Vaccines

(2011) Peng Xu et al.   BIOCONJUGATE CHEMISTRY

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

(2011) Elizabeth B. Norton et al.   Clinical and Vaccine Immunology

Antigen-Specific Memory B-Cell Responses in Bangladeshi Adults after One- or Two-Dose Oral Killed Cholera Vaccination and Comparison with Responses in Patients with Naturally Acquired Cholera

(2011) Mohammad Murshid Alam et al.   Clinical and Vaccine Immunology

Comparison of Memory B Cell, Antibody-Secreting Cell, and Plasma Antibody Responses in Young Children, Older Children, and Adults with Infection Caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh

(2011) Daniel T. Leung et al.   Clinical and Vaccine Immunology

Natural Cholera Infection-Derived Immunity in an Endemic Setting

(2011) M. Ali et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial

(2011) Dipika Sur et al.   PLoS Neglected Tropical Diseases

Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant

(2009) Aileen F. G. Bongat et al.   GLYCOCONJUGATE JOURNAL

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

(2009) Dipika Sur et al.   LANCET

Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice

(2009) Julianne E. Rollenhagen et al.   VACCINE

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin

(2009) Nancy A. Summerton et al.   VACCINE

Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh

(2008) Jason B. Harris et al.   PLoS Neglected Tropical Diseases

The High Burden of Cholera in Children: Comparison of Incidence from Endemic Areas in Asia and Africa

(2008) Jacqueline L. Deen et al.   PLoS Neglected Tropical Diseases

Preparation of glycoconjugates by dialkyl squarate chemistry revisited

(2007) Shu-jie Hou et al.   CARBOHYDRATE RESEARCH